Case report of aplastic anaemia detected in third trimester of pregnancy: dilemmas faced

Authors

  • Gayathri Dinesh Kamath Department of Obstetrics and Gynaecology, Fortis Hospital, Bannerghatta, Bangalore, Karnataka, India
  • Sunil Prabhakar Udgire Department of Haematology and Bone Marrow Transplantation, Sparsh Hospital Bangalore, Karnataka, India
  • Divya Katewa Department of Obstetrics and Gynaecology, Fortis Hospital, Bannerghatta, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20205804

Keywords:

Aplastic anaemia, Pregnancy, Eltrombopag

Abstract

Aplastic anaemia with pregnancy is rarely encountered. Management of aplastic anaemia in pregnancy primarily involves a multidisciplinary approach offering supportive care. Our case was challenging as she developed aplastic anaemia during the third trimester and had refractory thrombocytopenia. She required platelet transfusions on a daily basis for few weeks as well as packed red blood cells frequently. Her leucocyte count was low initially but improved quickly unlike the platelet counts. Initiation of immunosuppressive therapy turned out to be beneficial and culminated in a good outcome. After starting immunosuppressive therapy with eltrombopag and cyclosporine she drifted through term and achieved a normal vaginal delivery.

Author Biographies

Gayathri Dinesh Kamath, Department of Obstetrics and Gynaecology, Fortis Hospital, Bannerghatta, Bangalore, Karnataka, India

Senior Consultant ,Department of Obstetrics and Gynaecology

Sunil Prabhakar Udgire, Department of Haematology and Bone Marrow Transplantation, Sparsh Hospital Bangalore, Karnataka, India

CONSULTANT IN HAEMAT -ONCOLOGIST

SPARSH HOSPITAL

BANGALORE

 

Divya Katewa, Department of Obstetrics and Gynaecology, Fortis Hospital, Bannerghatta, Bangalore, Karnataka, India

ASSOCIATE CONSULTANT

FORTIS HOSPITAL

BANGALORE

References

Aitchison RG, Marsh JC, Hows JM, Gordon RNH, Smith EC. Pregnancy associated aplastic anaemia: A report of five cases and review of current Management. Bri J Haematol. 1989;73:541-5.

Townsley DM, Scheinberg P, Winkler T. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. N Eng J Med. 2017;376:1540-50.

Choudry VP, Gupta S, Gupta M, Kashyap. Pregnancy associated aplastic anaemia- a series of 10 cases with review of literature. Haematol. 2002:7:233-8.

Guidelines for the diagnosis and management of Adult Aplastic anemia. Bri J Haematology. 2016;172:187-207.

Tichelli A, Socie G, Marsh J, Barge R, Frickhofen N, McCann S. et al Outcome of pregnancy and disease course among women with aplastic anaemia treated with immunosuppression. Ann Intern Med. 2002;137:164-72.

Purushotahman J, Puthumana KJ, Kumar A, Innah SJ, Gilvaz S. A case of refractory immune thrombocytopenia in pregnancy managed with Eltrombopag. Asian J Tranfus Sci. 2016;10:155-8.

McKay DB, Josephson MA. Pregnancy in recipients of solid organs-effects on mother and child. N Eng J Med. 2006;354:1281-93.

Al Hammadi AM, Sallah S. Efficacy and safety of recombinant factor VIIa in the treatment of bleeding episode in patients with aplastic anaemia. J Thromb Haemost. 2007;5:435-6.

Riveros-Perez E, Hermesch AC, Barbour LA, Hawkins JL. Aplastic anaemia during pregnancy: a review of obstetric and anesthetic. Inte J Women’s Health. 2018:10:117-25.

Downloads

Published

2020-12-26

Issue

Section

Case Reports